PFE: Multiplikator rega marang pendapatan Pfizer Corporation

Pfizer Inc. (PFE) minimizes risks through a broad portfolio of vaccines and oncology drugs. The company's P/S ratio reflects valuation dynamics relative to sales, where the 2.60 mark characterizes this parameter. The holding is implementing "green chemistry" to reduce production toxicity. Business stability relies on patent protection and government healthcare spending.

Pfizer Corp (PFE) - Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Pfizer Corporation (PFE) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Kurs saham pfizer.com|PFE - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Kapitalisasi pasar Pfizer Corporation|PFE - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham Pfizer|PFE - Kapitalisasi Buku|Kapitalisasi Pasar marang Aset Bersih pfizer.com|PFE - Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Koefisien Total Utang marang Modal Pfizer Inc.|PFE - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Pfizer Corp|PFE - Gunggung utang perusahaan|Utang-utang marang nilai buku Pfizer Corporation|PFE - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Pfizer|Rasio jangkoan perantara pfizer.com

- indikator bathi lan kelipatan valuasi:

PFE - Bathi resik|Prakiraan bathi perusahaan Pfizer Inc.|PFE - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Pfizer Inc|PFE - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pfizer Corporation|PFE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Pfizer|PFE - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan pfizer.com|PFE - Wutah bathi ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Pfizer Inc.

- rincian pendapatan lan dodolan emiten:

PFE - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan pfizer.com|PFE - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Pfizer Corporation

Analisis umum perusahaan:PFE - pfizer.com

To protect capital from market volatility, it is essential for investors to correlate the market value of Pfizer Inc. (PFE) with its actual earnings. The company's global distribution scale and government contracts ensure revenue stability, making the price-to-sales ratio a key valuation tool: this metric indicates how many dollars of market capitalization are attributed to each unit of sales, helping to determine the asset's degree of overvaluation and avoid excessive portfolio risks.

Pesaing Pfizer Inc.

lilly.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ABBV (AbbVie)|Multiplikator rega marang pendapatan AstraZeneca Plc|NVS - Rasio rega marang pendapatan|Rasio rega marang dodolan MRK|NVO: Multiplikator P/S|Rasio rega marang dodolan AMGN (amgen.com)|SNY (Sanofi S.A.) - Multiplikator P/S|Bristol Myers Squibb Company (BMY) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan GSK (GSK plc)|TAK: Rasio rega marang dodolan|Multiplikator P/S TEVA (Teva Pharmaceutical Industries)|drreddys.com (RDY) - Rega marang dodolan|VTRS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ROIV (Roivant)|ZLAB (Zai Lab Ltd.) - Kapitalisasi marang pendapatan|Bausch Health Corp - Rasio kapitalisasi pasar marang pendapatan|COSM (Cosmos Health Inc.) - Multiplikator P/S